These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16423397)

  • 1. Autoreactivity of primary human immunoglobulins ancestral to hypermutated human antibodies that neutralize HCMV.
    McLean GR; Cho CW; Schrader JW
    Mol Immunol; 2006 May; 43(12):2012-22. PubMed ID: 16423397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.
    Lantto J; Lindroth Y; Ohlin M
    Eur J Immunol; 2002 Jun; 32(6):1659-69. PubMed ID: 12115649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
    Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
    Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D; Lennette E; Tugizov S; Pereira L
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.
    Britt WJ; Jarvis MA; Drummond DD; Mach M
    J Virol; 2005 Apr; 79(7):4066-79. PubMed ID: 15767408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
    Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
    J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of human cytomegalovirus by human primary immunoglobulins identifies an innate foundation to an adaptive immune response.
    McLean GR; Olsen OA; Watt IN; Rathanaswami P; Leslie KB; Babcook JS; Schrader JW
    J Immunol; 2005 Apr; 174(8):4768-78. PubMed ID: 15814702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties.
    Barrios Y; Knör S; Lantto J; Mach M; Ohlin M
    Mol Immunol; 2007 Feb; 44(5):680-90. PubMed ID: 16824601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.
    Thomson CA; Bryson S; McLean GR; Creagh AL; Pai EF; Schrader JW
    EMBO J; 2008 Oct; 27(19):2592-602. PubMed ID: 18772881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location, location, timing: analysis of cytomegalovirus epitopes for neutralizing antibodies.
    Schrader JW; McLean GR
    Immunol Lett; 2007 Sep; 112(1):58-60. PubMed ID: 17714794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B.
    Ohlin M; Owman H; Rioux JD; Newkirk MM; Borrebaeck CA
    Mol Immunol; 1994 Sep; 31(13):983-91. PubMed ID: 7521934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.
    Kauvar LM; Liu K; Park M; DeChene N; Stephenson R; Tenorio E; Ellsworth SL; Tabata T; Petitt M; Tsuge M; Fang-Hoover J; Adler SP; Cui X; McVoy MA; Pereira L
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1558-68. PubMed ID: 25534746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIVETS: the recombinant immunoglobulin and viral epitope tag system.
    McLean GR; Cho CW; Trotter B; Schrader JW
    J Immunol Methods; 2006 Aug; 315(1-2):208-13. PubMed ID: 16919678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-terminal residue of glycoprotein B is critical for neutralization of bovine herpesvirus 1.
    Okazaki K; Fujii S; Takada A; Kida H
    Virus Res; 2006 Feb; 115(2):105-11. PubMed ID: 16153736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a novel vaccine against human cytomegalovirus based on a chimeric Ad5F35 adenovirus vector expressing the immunodominant antigenic domain 1 epitope.
    Zhao P; Ma D; Yan S; Shao N; Zhang J; Bi Z; Dai J; Ji M; Ji C
    Intervirology; 2009; 52(1):35-42. PubMed ID: 19372702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conserved amino-acid residue mutations in epitope of human cytomegalovirus antigen M].
    Wang B; Liu Z; Liu Y; Shen B; Liu C; Shao N
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1128-32. PubMed ID: 18837384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals.
    Ayata M; Sugano T; Murayama T; Sakamuro D; Takegami T; Matsumoto Y; Furukawa T
    J Med Virol; 1994 Aug; 43(4):386-92. PubMed ID: 7525866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.
    Lantto J; Fletcher JM; Ohlin M
    J Gen Virol; 2002 Aug; 83(Pt 8):2001-2005. PubMed ID: 12124464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
    Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
    Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
    Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
    Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.